加和国际控股(08513) - 2021 Q3 - 季度财报

Financial Performance - For the nine months ended September 30, 2021, the group's unaudited revenue was approximately SGD 15.1 million, a decrease of about SGD 2.0 million or 11.7% compared to SGD 17.1 million for the same period in 2020[5] - The group's unaudited profit for the nine months ended September 30, 2021, was approximately SGD 0.3 million, down from SGD 0.8 million for the same period in 2020[5] - Basic and diluted earnings per share for the nine months ended September 30, 2021, were SGD 0.09 and SGD 0.08, respectively, compared to SGD 0.16 and SGD 0.15 for the same period in 2020[5] - The total comprehensive income for the nine months ended September 30, 2021, was SGD 342,000, compared to SGD 833,000 for the same period in 2020[10] - The operating profit for the nine months ended September 30, 2021, was SGD 566,000, a decrease from SGD 1.4 million for the same period in 2020[8] - The group reported a net profit before tax of SGD 379,000 for the nine months ended September 30, 2021, compared to SGD 1.2 million for the same period in 2020[8] - The company reported a net profit attributable to equity holders of SGD 403,000 for the nine months ended September 30, 2021, a decline of 44.9% compared to SGD 731,000 in 2020[34] - The group recorded a net profit of approximately SGD 0.3 million for the nine months ended September 30, 2021, a decrease of about 62.5% from SGD 0.8 million for the same period in 2020[41] Revenue and Expenses - Revenue for the nine months ended September 30, 2021, was SGD 15,120,000, a decrease of 11.8% from SGD 17,140,000 in the same period of 2020[18] - The cost of goods sold for the nine months ended September 30, 2021, was SGD 6,028,000, down 23.1% from SGD 7,838,000 in 2020[20] - Total expenses for the nine months ended September 30, 2021, were SGD 14,625,000, a decrease of 12.0% from SGD 16,623,000 in 2020[20] - Administrative expenses decreased by approximately SGD 0.8 million or 24.2% to about SGD 2.5 million, mainly due to reductions in legal and professional fees and salaries related to the Chinese wine trading business[50] - Interest expenses for the nine months ended September 30, 2021, totaled SGD 187,000, a decrease of 19.7% from SGD 233,000 in 2020[22] - The total tax expense for the nine months ended September 30, 2021, was SGD 125,000, down from SGD 386,000 in 2020, representing a decline of 67.6%[23] Dividends and Shareholder Information - The board of directors does not recommend the payment of a dividend for the nine months ended September 30, 2021[6] - The company did not declare an interim dividend for the nine months ended September 30, 2021[38] - As of September 30, 2021, the major shareholder, 添運環球有限公司, holds 204,000,000 shares, representing 44.35% of the company's total shares[66] Business Operations - The group operates primarily in the manufacturing and sales of disposable medical devices and related services in Singapore, as well as trading of Chinese liquor and development of gaming machines in China[13] - Revenue decreased by approximately SGD 2.0 million or 11.7% to about SGD 15.1 million for the nine months ended September 30, 2021, primarily due to reduced revenue from the development, manufacturing, and sales of gaming machines and equipment in China[46] - The overall gross profit decreased by approximately SGD 0.7 million or 17.1% to about SGD 3.4 million, with the gross profit margin declining from approximately 24.0% to 22.5%[48] Research and Development - Research and development expenses increased to SGD 325,000 in 2021 from SGD 271,000 in 2020, reflecting a growth of 19.9%[20] Corporate Governance - The company has complied with the corporate governance code, except for the provision that the roles of chairman and CEO should be separated, which is currently not the case[77] - The audit committee, consisting of three independent non-executive directors, is responsible for reviewing financial statements and overseeing internal control procedures[79] - The unaudited consolidated financial information for the nine months ending September 30, 2021, has been discussed and reviewed by the audit committee, ensuring compliance with applicable accounting standards[82] Stock Options and Securities - The stock option plan adopted on December 19, 2017, allows for the issuance of 40,000,000 stock options, which is approximately 8.7% of the total issued shares as of September 30, 2021[70] - No stock options were granted during the nine months ending September 30, 2021, and there were no unexercised stock options as of that date[74] - The company has not purchased, sold, or redeemed any of its listed securities during the nine months ending September 30, 2021[69] Acquisitions and Disposals - There were no significant acquisitions or disposals of subsidiaries during the nine months ended September 30, 2021[39]